Results 161 to 170 of about 14,924 (223)

Association of maternal immunoglobulin G levels with pregnancy outcomes in primary immunodeficiency: A retrospective single-center study. [PDF]

open access: yesMedicine (Baltimore)
Gerek ME   +9 more
europepmc   +1 more source

Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Banks SA   +4 more
europepmc   +1 more source

Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia

European Journal of Internal Medicine, 2014
Although secondary hypogammaglobulinemia is more frequent than primary hypogammaglobulinemia, its etiology and management are poorly described, particularly for mild hypogammaglobulinemia.This retrospective observational study included all adult patients with a gammaglobulin level
Mathieu Blot   +2 more
exaly   +3 more sources

Differential Diagnosis in Hypogammaglobulinemia

open access: yes, 2018
Hypogammaglobulinemia is defined as an impaired production of antibodies. This condition represents a diagnostic challenge for clinicians, due to its association with many pathological entities with different manifestations and outcomes. Primary hypogammaglobulinemia is caused by defects in B-cell number and maturation, reduced survival and activation ...
Quinti, Isabella   +3 more
openaire   +2 more sources

Transient hypogammaglobulinemia and unclassified hypogammaglobulinemia: ‘Similarities and differences’

open access: yesPediatric Allergy and Immunology, 2010
Transient hypogammaglobulinemia of infancy (THI) is characterized by recurrent infections and one or more reduced serum immunoglobulin (Ig) levels. Usually, this clinical picture resolves spontaneously by 3 yr of age.
Sevgi Keles, , Ahmet Özen
exaly   +2 more sources

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

open access: yesJournal of Autoimmunity, 2015
Rituximab is a B cell depleting monoclonal antibody used to treat lymphoma and autoimmune disease. Hypogammaglobulinemia has occurred after rituximab for lymphoma and rheumatoid arthritis but dataare scarce for other autoimmune indications.
Darren M Roberts   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy